Kovack Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Kovack Advisors's BMY Position: Q2 2026 in Review
Kovack Advisors reduced its Bristol-Myers Squibb (BMY) stake by 2.9% in Q2 2026, selling an estimated $58.7K and leaving 34,471 shares worth $1.97M. The position accounts for 0.09% of the portfolio, ranked #215.
Kovack Advisors first reported a position in BMY in Q3 2013 and has held it in 52 quarters since. The position peaked at $2.17M in Q1 2026. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Kovack Advisors held 34,471 shares of Bristol-Myers Squibb worth $1.97M as of Q2 2026.
- Kovack Advisors sold 1,022 Bristol-Myers Squibb shares in Q2 2026, an estimated $58.7K.
- Bristol-Myers Squibb made up 0.09% of Kovack Advisors's portfolio in Q2 2026, its #215 holding.
- Kovack Advisors first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 52 quarters since.
- Kovack Advisors's Bristol-Myers Squibb position peaked at $2.17M in Q1 2026.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.